Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ethgen · SciRah

Researcher profile · Semantic Scholar

D. Ethgen

Share profile

D. Ethgen — researcher profile on SciRah

h-index: 18
Works: 48
Citations: 3,307

Most-cited papers

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
J. Reginster, H. Minne, O. H. Sørensen, M. Hooper +7 more
2000Osteoporosis International1,659 citations
Semantic Scholar
Sifalimumab, a Human Anti–Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
M. Petri, Daniel J. Wallace, A. Spindler, V. Chindalore +10 more
2013Arthritis & Rheumatism258 citations Open access
Semantic Scholar
Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.
I. Fogelman, C. Ribot, Roger Smith, D. Ethgen +2 more
2000Journal of Clinical Endocrinology and Metabolism228 citations
Semantic Scholar
Prevention of postmenopausal bone loss by tiludronate
J. Reginster, MP Lecart, R. Deroisy, N. Sarlet +4 more
1989The Lancet166 citations
Semantic Scholar
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
E. Abadie, D. Ethgen, B. Avouac, G. Bouvenot +14 more
2004Osteoarthritis and Cartilage140 citations Open access
Semantic Scholar
Adherence to treatment of osteoporosis: a need for study
F. Lekkerkerker, J. Kanis, N. Alsayed, G. Bouvenot +19 more
2007Osteoporosis International127 citations Open access
Semantic Scholar
Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section.
M. Dougados, J. Devogelaer, M. Annefeldt, B. Avouac +21 more
1996Annals of the Rheumatic Diseases119 citations Open access
Semantic Scholar
Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study
O. Bruyère, J. Collette, M. Kothari, S. Zaim +8 more
2006Annals of the Rheumatic Diseases101 citations Open access
Semantic Scholar
Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritis.
O. Bruyère, H. Genant, M. Kothari, S. Zaim +8 more
2007Osteoarthritis and Cartilage96 citations Open access
Semantic Scholar
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.
J. Goldhahn, W. Scheele, B. Mitlak, E. Abadie +20 more
2008Bone62 citations Open access
Semantic Scholar
Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
J. Reginster, F. Colson, G. Morlock, B. Combe +2 more
1992Arthritis & Rheumatism48 citations Open access
Semantic Scholar
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies
P. Miossec, C. Verweij, L. Klareskog, C. Pitzalis +16 more
2011Annals of the Rheumatic Diseases42 citations Open access
Semantic Scholar
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men
J. Reginster, E. Abadie, P. Delmas, R. Rizzoli +20 more
2005Osteoporosis International37 citations
Semantic Scholar
Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus
M. Petri, A. Kawata, Ancilla W. Fernandes, K. Gajria +3 more
2013Journal of Rheumatology35 citations Open access
Semantic Scholar
Risedronate reduces hip fractures in patients with low femoral neck bone mineral density
P. Miller, C. Roux, M. McClung, S. Adami +4 more
199925 citations
Semantic Scholar
Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of paget's disease of bone
J. Reginster, R. Trèves, J. Rénier, B. Amor +4 more
1994Journal of Bone and Mineral Research25 citations
Semantic Scholar
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.
E. Abadie, Jean-Pierre Devogealer, J. Ringe, D. Ethgen +15 more
2005Seminars in Arthritis & Rheumatism24 citations
Semantic Scholar
Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis.
B. Zegels, R. Eastell, Roslin Russell, D. Ethgen +3 more
2001Bone20 citations
Semantic Scholar
Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study.
R. Recker, L. Ste-Marie, B. Langdahl, D. Masanauskaite +2 more
2009Journal of clinical densitometry17 citations
Semantic Scholar
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA
J. Smolen, M. Boers, E. Abadie, F. Breedveld +19 more
2011Current Medical Research and Opinion13 citations
Semantic Scholar
Paget's disease of bone treated with a five day course of oral tiludronate.
J. Reginster, Marie-Paule Lecart, R. Deroisy, D. Ethgen +2 more
1993Annals of the Rheumatic Diseases13 citations Open access
Semantic Scholar
Risedronate reduces fracture risk in women with established postmenopausal osteoporosis
R. Eastell, H. Minne, O. Sørensen, M. Hooper +5 more
199912 citations
Semantic Scholar
Long-lasting dermatological lesions after tiludronate therapy
Christian Roux, V. Listrat, B. Villette, M. Lessana-Leibowitch +4 more
1992Calcified Tissue International9 citations
Semantic Scholar
Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section.
E. Lemmel, D. Reid, G. Nuki, B. Avouac +16 more
1998British Journal of Rheumatology8 citations
Semantic Scholar
Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density
C. Ribot, Roger Smith, I. Fogelman, P. Bettica +3 more
19995 citations
Semantic Scholar
Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass
I. Fogelman, C. Ribot, Roger Smith, P. Bettica +3 more
19994 citations
Semantic Scholar
Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis.
J. Smolen, M. Boers, E. Abadie, F. Breedveld +11 more
2011Rheumatology3 citations
Semantic Scholar
Evaluation of efficacy and safety of oral tiludronate in Paget's disease of bone: a double-blind, dose-ranging, placebo-controlled study
J. Reginster, F. Colson, G. Morlock, B. Combe +2 more
19933 citations
Semantic Scholar
68 Regional Differences of Spinal BMD Changes After One Year Once-Monthly Ibandronate as Measured by 3D QCT
K. Engelke, T. Fuerst, M. B. Enslin, R. Davies +3 more
20092 citations
Semantic Scholar
Efficacy and tolerance of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone
J. Reginster, R. Trèves, J. Rénier, B. Amor +3 more
19932 citations
Semantic Scholar
Treatment of Paget’s disease of bone with high doses of oral tiludronate given during a five-day course therapy
J. Reginster, Marie-Paule Lecart, R. Deroisy, N. Sarlet +2 more
19902 citations
Semantic Scholar
[Alveolar echinococcosis with spinal localization].
A. Gaucher, E. Vinet, P. Péré, F. Plénat +2 more
1983Presse medicale2 citations
Semantic Scholar
Longitudinal study of magnetic resonance imaging and fixed-flexion radiography to assess progression of osteoarthritis of the knee
O. Bruyère, M. Kothari, C. Peterfy, S. Zaim +8 more
20060 citations
Semantic Scholar
Magnetic Resonance Imaging and biochemical markers of osteoarthritis of the knee
M. Kothari, O. Bruyère, J. Collette, C. Peterfy +8 more
20050 citations
Semantic Scholar
One-year progression of knee osteoarthritis: correlations between X-Rays and magnetic resonance imaging changes
O. Bruyère, M. Kothari, S. Zaim, D. White +7 more
20050 citations
Semantic Scholar
Longitudinal study of magnetic resonance imaging and fixed-flexion radiography to assess progression of osteoarthritis of the knee
M. Kothari, C. Peterfy, O. Bruyère, S. Zaim +7 more
20050 citations
Semantic Scholar
Knee whole-organ MRI score (WORMS) as a surrogate marker for X-ray joint space narrowing
O. Bruyère, M. Kothari, S. Zaim, D. White +5 more
20050 citations
Semantic Scholar
Femoro-tibial joint space width, assessed by standard X-Ray, is associated with tibial cartilage volume and thickness, assessed by magnetic resonance imaging
O. Bruyère, M. Kothari, S. Zaim, D. White +7 more
20050 citations
Semantic Scholar
Baseline hyaluronic acid measurement predicts one-year changes in knee magnetic resonance imaging global score (WORMS) in patients with knee osteoarthritis
O. Bruyère, J. Collette, M. Kothari, S. Zaim +6 more
20050 citations
Semantic Scholar
Recommandations for Health Economics Evaluations of interventions in Osteoporosis
J. Reginster, Henry-Jean Gathon, A. Marciniak, W. Ben Sedrine +8 more
19990 citations
Semantic Scholar
Risedronate significantly reduces vertebral and non-vertebral fractures in osteoporotic women
C. Roux, M. Keller, R. Eastell, C. McKeever +4 more
19990 citations
Semantic Scholar
Comparative analysis of healthcare use in patients with rheumatoid arthritis and control subjects without chronic disease
O. Ethgen, D. Ethgen, F. Guillemin, J. Reginster
19970 citations
Semantic Scholar
Oral Tiludronate: a new perspective for prevention and treatment of postmenopausal osteoporosis
J. Reginster, D. Ethgen, A. Barbier, P. Geusens +2 more
19930 citations
Semantic Scholar
Evidence that tiludronate is an interesting perspective for prevention and treatment of postmenopausal osteoporosis
J. Reginster, D. Ethgen, A. Barbier, P. Geusens +5 more
19930 citations
Semantic Scholar
Paget's disease ofbonetreated with afive daycourse oforaltiludronate
J. Reginster, M. Lecart, R. Deroisy, D. Ethgen +2 more
19930 citations
Semantic Scholar
Evidence that oral tiludronate is a first line prevention of postmenopausal osteoporosis
J. Reginster, D. Ethgen, R. Deroisy, P. Franchimont
19910 citations
Semantic Scholar
[Study of osteoarticular infections. Sequential scintigraphy with gallium-67 citrate and technetium phosphate complexes].
A. Gaucher, P. Péré, D. Ethgen, A. Bertrand +1 more
1983Presse medicale0 citations
Semantic Scholar
[Scintigraphic study of reflex algodystrophy].
A. Gaucher, P. Raul, P. Wiederkehr, J. Pourel +3 more
1982Revue du rhumatisme et des maladies osteo-articulaires0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Reginster×32
Invite
J. Reginster — researcher profile on SciRah
N. Burlet×11
Invite
N. Burlet — researcher profile on SciRah
M. Kothari×9
Invite
M. Kothari — researcher profile on SciRah
S. Zaim×9
Invite
S. Zaim — researcher profile on SciRah

×8

Invite

O. Bruyère — researcher profile on SciRah

Invite

A. Laslop — researcher profile on SciRah

Invite

C. Peterfy — researcher profile on SciRah

Invite

T. Montague — researcher profile on SciRah

Invite

B. Avouac — researcher profile on SciRah

Invite

S. Pack — researcher profile on SciRah

Invite

E. Abadie — researcher profile on SciRah

Invite

B. Mitlak — researcher profile on SciRah